Cross-linked polyethylene and bisphosphonate therapy for osteolysis in total hip arthroplasty: a case report

J Orthop Surg (Hong Kong). 2004 Jun;12(1):114-21. doi: 10.1177/230949900401200121.

Abstract

A 39-year-old woman underwent bilateral total hip arthroplasty with conventional, ethylene oxide-sterilised liners when she was a subject in a radiostereometric analysis study. Within 2 years she had rapid polyethylene wear with aggressive, asymptomatic, and periprosthetic osteolysis on both sides. Oral alendronate therapy halted the progression of osteolysis over a year and revision to cross-linked polyethylene liners was then undertaken while one stem was curettaged and the other revised. Radiostereometric analysis revealed a 96% reduction in wear rate over 2 years with the cross-linked liners. On stopping alendronate treatment, aggressive osteolysis recurred on the curretaged but not on the revised femur.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adult
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Arthroplasty, Replacement, Hip / methods
  • Diphosphonates / therapeutic use*
  • Female
  • Follow-Up Studies
  • Hip Prosthesis*
  • Humans
  • Joint Instability / etiology
  • Joint Instability / prevention & control
  • Osteoarthritis, Hip / diagnostic imaging
  • Osteoarthritis, Hip / surgery
  • Osteolysis / diagnostic imaging
  • Osteolysis / drug therapy*
  • Osteolysis / etiology
  • Pain Measurement
  • Polyethylene / pharmacology*
  • Prosthesis Design
  • Prosthesis Failure*
  • Radiography
  • Range of Motion, Articular / physiology
  • Recovery of Function
  • Reoperation
  • Treatment Outcome

Substances

  • Diphosphonates
  • Polyethylene